Skip to main content
. 2022 Oct 21;12:17723. doi: 10.1038/s41598-022-22859-w

Table 1.

Patient characteristics in all performed cycles.

Overall NR POSEIDON p
1 2 3 4
No. cycles 374 124 53 77 36 84
Age (yrs)a 35.47 (4.28) 33.59 (3.93) 32.32 (1.66) 37.56 (2.31) 31.97 (2.50) 39.81 (3.20) 0.000
No. prev. preg.b 0.00 [0.00, 8.00] 0.00 [0.00, 5.00] 0.00 [0.00, 5.00] 1.00 [0.00, 5.00] 0.00 [0.00, 5.00] 1.00 [0.00, 8.00] 0.000
HT (m)a 1.61 (0.05) 1.61 (0.05) 1.60 (0.05) 1.61 (0.05) 1.60 (0.06) 1.62 (0.05) 0.321
BW (kg)a 59.21 (10.62) 60.14 (10.70) 56.19 (8.24) 58.26 (8.79) 56.61 (15.74) 61.71 (10.09) 0.007
BMI (kg/m2)a 22.80 (3.89) 23.19 (3.93) 21.88 (3.40) 22.32 (3.01) 22.15 (6.45) 23.51 (3.23) 0.027
Infert. Dur. (mo)b 24.00 [1.00, 156.00] 24.00 [2.00, 144.00] 36.00 [8.00, 120.00] 36.00 [1.00, 156.00] 24.00 [5.00, 72.00] 26.00 [2.00, 144.00] 0.000
Infert type (%)c
Prim 233 (62.3) 95 (76.6) 40 (75.5) 33 (42.9) 31 (86.1) 33 (39.3) 0.000
Sec 141 (37.7) 29 (23.4) 13 (24.5) 44 (57.1) 5 (13.9) 51 (60.7)
Infert factor (%)c
Male 67 (17.9) 33 (26.6) 15 (28.3) 9 (11.7) 2 (5.6) 8 (9.5) 0.000
Female 172 (46.0) 59 (47.6) 19 (35.8) 33 (42.9) 16 (44.4) 45 (53.6)
Both 32 (8.6) 10 (8.1) 7 (13.2) 10 (13.0) 1 (2.8) 4 (4.8)
Unexpl 103 (27.5) 22 (17.7) 12 (22.6) 25 (32.5) 17 (47.2) 27 (32.1)
FSHb (mIU/mL) 6.17 [0.11, 49.19] 5.01 [0.11, 14.20] 7.12 [1.20, 14.20] 6.35 [2.47, 34.64] 6.90 [1.84, 49.19] 7.74 [0.19, 30.60] 0.000
AMHb (ng/mL) 2.08 [0.01, 23.94] 4.51 [1.44, 23.94] 2.87 [1.23, 12.31] 1.78 [0.77, 7.26] 0.31 [0.01, 4.15] 0.40 [0.02, 1.17] 0.000
AFCb 8.00 [0.00, 39.00] 12.00 [2.00, 39.00] 10.00 [0.00, 16.00] 8.00 [2.00, 18.00] 5.00 [2.00, 8.00] 3.00 [0.00, 10.00] 0.000
Preov. fol.b 10.00 [1.00, 76.00] 21.00 [10.00, 76.00] 10.00 [2.00, 18.00] 9.00 [1.00, 18.00] 5.00 [1.00, 21.00] 4.00 [1.00, 42.00] 0.000

Continuous variables are presented as either amean (SD) or bmedian [interquartile range]. Categorical variables are presented as cnumber of cycles (%). A p-value < 0.05 was considered statistically significant. NR normal responder, No. number, yrs years, prev. previous, HT height, BW body weight, BMI body mass index, Infert. Infertility, Dur. Duration, mo months, prim. Primary, sec. secondary, unexpl. Unexplained, FSH follicle stimulation hormone, AMH anti-Mullerian-hormone, AFC antral follicle count, Preov. fol. preovulatory follicles, POSEIDON patient-oriented strategies encompassing individualized oocyte number.